Stockreport

BioMarin's Amicus Deal Funding Reshapes Debt Load And Rare Disease Reach [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF BioMarin Pharmaceutical (NasdaqGS:BMRN) announced a major debt financing package to support its pending acquisition of Amicus Therapeutics. The company plans to offer [Read more]